全文获取类型
收费全文 | 3337篇 |
免费 | 230篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 128篇 |
妇产科学 | 92篇 |
基础医学 | 474篇 |
口腔科学 | 124篇 |
临床医学 | 316篇 |
内科学 | 625篇 |
皮肤病学 | 26篇 |
神经病学 | 274篇 |
特种医学 | 127篇 |
外科学 | 336篇 |
综合类 | 23篇 |
一般理论 | 4篇 |
预防医学 | 289篇 |
眼科学 | 63篇 |
药学 | 351篇 |
中国医学 | 1篇 |
肿瘤学 | 262篇 |
出版年
2023年 | 16篇 |
2022年 | 21篇 |
2021年 | 43篇 |
2020年 | 53篇 |
2019年 | 72篇 |
2018年 | 87篇 |
2017年 | 68篇 |
2016年 | 98篇 |
2015年 | 99篇 |
2014年 | 112篇 |
2013年 | 180篇 |
2012年 | 233篇 |
2011年 | 219篇 |
2010年 | 135篇 |
2009年 | 131篇 |
2008年 | 233篇 |
2007年 | 241篇 |
2006年 | 252篇 |
2005年 | 195篇 |
2004年 | 192篇 |
2003年 | 158篇 |
2002年 | 183篇 |
2001年 | 27篇 |
2000年 | 27篇 |
1999年 | 29篇 |
1998年 | 44篇 |
1997年 | 42篇 |
1996年 | 53篇 |
1995年 | 27篇 |
1994年 | 25篇 |
1993年 | 24篇 |
1992年 | 13篇 |
1991年 | 18篇 |
1990年 | 21篇 |
1989年 | 20篇 |
1988年 | 17篇 |
1987年 | 13篇 |
1986年 | 11篇 |
1985年 | 16篇 |
1984年 | 15篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 15篇 |
1978年 | 14篇 |
1977年 | 10篇 |
1975年 | 9篇 |
1972年 | 5篇 |
1967年 | 4篇 |
排序方式: 共有3572条查询结果,搜索用时 15 毫秒
91.
Lena Nordström Sandra Sernbo Patrik Eden Kirsten Grønbæk Arne Kolstad Riikka Räty Marja‐Liisa Karjalainen Christian Geisler Elisabeth Ralfkiær Christer Sundström Anna Laurell Jan Delabie Mats Ehinger Mats Jerkeman Sara Ek 《British journal of haematology》2014,166(1):98-108
Mantle cell lymphoma (MCL) is an aggressive B cell lymphoma, where survival has been remarkably improved by use of protocols including high dose cytarabine, rituximab and autologous stem cell transplantation, such as the Nordic MCL2/3 protocols. In 2008, a MCL international prognostic index (MIPI) was created to enable stratification of the clinical diverse MCL patients into three risk groups. So far, use of the MIPI in clinical routine has been limited, as it has been shown that it inadequately separates low and intermediate risk group patients. To improve outcome and minimize treatment‐related morbidity, additional parameters need to be evaluated to enable risk‐adapted treatment selection. We have investigated the individual prognostic role of the MIPI and molecular markers including SOX11, TP53 (p53), MKI67 (Ki‐67) and CCND1 (cyclin D1). Furthermore, we explored the possibility of creating an improved prognostic tool by combining the MIPI with information on molecular markers. SOX11 was shown to significantly add prognostic information to the MIPI, but in multivariate analysis TP53 was the only significant independent molecular marker. Based on these findings, we propose that TP53 and SOX11 should routinely be assessed and that a combined TP53/MIPI score may be used to guide treatment decisions. 相似文献
92.
Raheel A. Raja Kjeld Schmiegelow Birgitte K. Albertsen Kaie Prunsild Bernward Zeller Goda Vaitkeviciene Jonas Abrahamsson Mats Heyman Mervi Taskinen Arja Harila‐Saari Jukka Kanerva Thomas L. Frandsen the Nordic Society of Paediatric Haematology Oncology group 《British journal of haematology》2014,165(1):126-133
L‐asparaginase is an important drug in the treatment of childhood acute lymphoblastic leukaemia (ALL). Treatment is associated with several toxicities, including acute pancreatitis. Clinical course, presentation, re‐exposure to L‐asparginase after pancreatitis and risk of recurrent pancreatitis within an asparaginase‐intensive protocol has been poorly reported. Children (1–17 years) on the ongoing Nordic Society of Paediatric Haematology and Oncology (NOPHO) ALL2008 protocol with asparaginase‐associated pancreatitis (AAP) diagnosed between 2008 and 2012 were identified through the online NOPHO ALL toxicity registry. NOPHO ALL2008 includes eight or 15 doses of intramuscular pegylated L‐asparginase (PEG‐asparaginase) 1000 iu/m2/dose at 2–6 weeks intervals, with a total of 30 weeks of exposure to PEG‐asparaginase (clinicaltrials.gov no: NCT00819351). Of 786 children, 45 were diagnosed with AAP with a cumulative risk of AAP of 5·9%. AAP occurred after a median of five doses (range 1–13), and 11 d (median) from the latest administration of PEG‐Asparaginase. Thirteen patients developed pseudocysts (30%) and 11 patients developed necrosis (25%). One patient died from pancreatitis. Twelve AAP patients were re‐exposed to L‐asparginase, two of whom developed mild AAP once more, after four and six doses respectively. In conclusion, re‐exposure to PEG‐asparaginase in ALL patients with mild AAP seems safe. 相似文献
93.
94.
95.
96.
Rego EH Shao L Macklin JJ Winoto L Johansson GA Kamps-Hughes N Davidson MW Gustafsson MG 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(3):E135-E143
Using ultralow light intensities that are well suited for investigating biological samples, we demonstrate whole-cell superresolution imaging by nonlinear structured-illumination microscopy. Structured-illumination microscopy can increase the spatial resolution of a wide-field light microscope by a factor of two, with greater resolution extension possible if the emission rate of the sample responds nonlinearly to the illumination intensity. Saturating the fluorophore excited state is one such nonlinear response, and a realization of this idea, saturated structured-illumination microscopy, has achieved approximately 50-nm resolution on dye-filled polystyrene beads. Unfortunately, because saturation requires extremely high light intensities that are likely to accelerate photobleaching and damage even fixed tissue, this implementation is of limited use for studying biological samples. Here, reversible photoswitching of a fluorescent protein provides the required nonlinearity at light intensities six orders of magnitude lower than those needed for saturation. We experimentally demonstrate approximately 40-nm resolution on purified microtubules labeled with the fluorescent photoswitchable protein Dronpa, and we visualize cellular structures by imaging the mammalian nuclear pore and actin cytoskeleton. As a result, nonlinear structured-illumination microscopy is now a biologically compatible superresolution imaging method. 相似文献
97.
98.
Ambrosi A Salomonsson S Eliasson H Zeffer E Skog A Dzikaite V Bergman G Fernlund E Tingström J Theander E Rydberg A Skogh T Öhman A Lundström U Mellander M Winqvist O Fored M Ekbom A Alfredsson L Källberg H Olsson T Gadler F Jonzon A Kockum I Sonesson SE Wahren-Herlenius M 《Annals of the rheumatic diseases》2012,71(3):334-340
99.
100.
Fredrik J. Vang Mats Lindström Charlotta Sunnqvist Jessica Bah-Rösman Aki Johanson Lil Träskman-Bendz 《Archives of Suicide Research》2013,17(3):214-229
In this study, we investigated how adversities related to past and present morbidity, and genotype. Forty-two, suicide attempters and 22 matched control patients were followed-up after 13 years. Life-time adversities were explored in an interview, and the patients were reassessed psychiatrically. The serotonin-transporter-linked promotor region (5-HTTLPR) was typed. More adversities were reported by suicide attempters than controls, and by still-ill than recovered suicide attempters. Adversities reported at follow-up were related to psychiatric morbidity at follow-up, but not to morbidity 13 years earlier. The 5-HTTLPR, genotype was associated with reported adversities, but not chances of recovery. Adversities potentially affected chronic morbidity. 5-HTTLPR genotype did not affect long-term recovery. 相似文献